inotuzumab
pfizer,ucb pharmaceuticals
['bet', '2000', 'leukemia', '2019', 'inotuzumab', 'novo ']
#ash22 inotuzumab ozogamicin induction followed by standard chemo yields high rr and promising survival in older (55 years) patients with de novo b-all (gmall-initial1 trial) &gt; low toxicity (1/2) 
Adult BMT & Cellular Therapy @MountSinaiNYC @TischCancer Founder: https://t.co/LFdHmTq9L3… Passion for #bmt #cart #photography #poetry ????? ??